This program focuses on identifying the causes and cures of Type 1 (autoimmune) diabetes through basic and clinical research.
This program's mission is to understand the relationship between the immune system and diseases and to design new therapies.
This program acts as an interface between the laboratory researchers, clinicians and patients to translate scientific knowledge into clinical trials.
This program focuses on diseases of the body’s tissues, heart and blood vessels—and conducts basic and translational research.
This program conducts clinical trials of new therapeutics, and studies clinical outcomes.
Learn about our researchers.
Spotlight
Join athletes from all around the Pacific Northwest in the BRI Triathlon at Seafair, Sunday, July 20, at Seward Park.
Read more
News & Events
-
Predicting and Preventing Autoimmune Disease on UWTV Read more
-
Life Sciences Discovery Fund Awards BRI $5.57 Million for Autoimmune Disease Research Read more
-
BRI Receives $5.3 Million for Allergy Studies Read more
-
Upcoming Type 1 Diabetes Screenings Read more
How BRI Can Help You
How to Participate
